B-cell cloning, a recent improvement over typical hybridoma technology, is becoming an industry standard tool for the reliable and reproducible production of monoclonal antibodies. Read on to find out how we have successfully utilized B-cell cloning to produce antibody critical reagents, for a recombinant protein, and to learn how this …
![Scientist](https://ddblog.labcorp.com/wp-content/uploads/2021/11/blog-450x300.png)